ONL Therapeutics to Present at the XXVth Biennial Meeting
Oral presentation will review the scientific rationale for Fas receptor inhibition, a unique mechanism-of-action, in
Globe Newswire13-02-2023, 19:03
Acronis CEO, Patrick Pulvermueller, Honored on CRN’s Top 100 Executives List for the Third Consecutive Year 31-07-2023, 21:09
